Arteriocyte is now a part of Isto Biologics.

News + Views


Cell-Based Therapy Shines in Clinical Settings

Apr 21, 2015

Cell-based therapy is becoming increasingly prominent as the demand for orthopedic treatments grows.

As people live longer and maintain greater physical activity later in life, the demand for orthopedic intervention is on the rise. Fortunately, cell-based therapy, which has become increasingly prominent in the medical world in the past few years, may provide a solution for people seeking cartilage, tendon or bone repair.

Orthopedic Surgeons Embrace Cell-Based Therapy
In a March 2015 San Antonio Express-News feature, doctors from San Antonio discussed the vast potential that lies in treatments that use a patient’s own cells to repair various tissues, including bone and cartilage. It can be especially beneficial to older adults, who may be more susceptible to orthopedic injury and often experience pain and inflammation caused by wear and tear that comes with age.

However, as anesthesiologist and pain-management specialist Dr. John Hall told the source, he and his partners at the The Stem Cell Orthopedic Institute of Texas see many more younger patients than would be expected.

“There’s a lot of younger people getting severe joint damage,” Hall explained. “Now there’s an alternative for them to surgery.”

The alternative Hall is referring to is a recent advancement in the world of cell-based therapy. It involves withdrawing bone marrow from a patient’s body, generally the hip, and injecting derived cells directly into the treatment area. The procedure typically lasts an hour and requires only minor sedation.

“This is a very straightforward application of cells from your own body,” Dr. Ajeya Joshi, a Stem Cell Orthopedic Institute of Texas orthopedic spinal surgeon, told San Antonio Express-News.

ISTO Technologies’ Orthobiologics Solutions
As a leader in orthobiologics, ISTO Technology strives to provide solutions to advance orthopedic treatments into the next era. For instance, the CellPoint Concentrated Bone Marrow Aspirate System, which was recently introduced to the market, was developed to aid clinicians in the process of recovering concentrated bone marrow aspirate for a variety of uses.

CellPoint requires minimal set-up and prep time (generally fewer than 20 minutes), and the cBMA-focused design allows the delivery of a high concentration of cells. Additionally, the system is fully automated thanks to an optical sensor that detects cell fraction, thereby eliminating the need for operator intervention.

To top